Adtalem finalizes separation agreement with ex-President Danaher; details severance terms

Covista Inc.

Severance of $1,014,390 (1x salary + 70% MIP target) payable in 12 monthly installments.
FY23 MIP award set to 0% by CEO; no FY23 payout and no pro-rated FY24 MIP.
Unvested LTI awards (RSUs, PSUs, options) will continue to vest per award agreements.
One-time lump sum of $14,513 for COBRA subsidy for dependents; counsel fees of $62,000 paid.
Standard noncompete, nonsolicitation, confidentiality covenants apply.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. John Danaher

President, Medical & Veterinary

CVSA · Covista Inc.

Effective: 2023-09-15
Filed: April 12, 2024, 7:59 PM ET

reporting that Dr. John Danaher President, Medical & Veterinary was leaving Adtalem effective September 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. John Danaher departed as President, Medical & Veterinary at Covista Inc..

Action: left
Role: President, Medical & Veterinary

Exact text from the filing

reporting that Dr. John Danaher President, Medical & Veterinary was leaving Adtalem effective September 15, 2023.

View on SEC.gov

Covista Inc. filing history →

Source: SEC EDGAR

accession 0000730464-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.